OVID
Ovid Therapeutics·NASDAQ
--
--(--)
--
--(--)
OVID fundamentals
During Q4 2025, Ovid Therapeutics (OVID) reported revenue of 718.00K, a YoY change of 844.74%. Net income was 9.66M, a YoY change of 204.43%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 6.91M -- | 5.70M -- | 208.38M -- | 0 -- | 0 -100.00% | 0 -100.00% | 1.45M -99.31% | 0 -- | 11.10K -- | 46.28K -- | 66.00K -95.43% | 75.00K -- | 109.00K +881.81% | 142.00K +206.83% | 148.00K +124.24% | 169.00K +125.33% | 173.00K +58.72% | 76.00K -46.48% | 130.00K -12.16% | 6.27M +3611.24% | 132.00K -23.70% | 718.00K +844.74% | 7.25M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 6.91M -- | 5.70M -- | 208.38M -- | 0 -- | 0 -100.00% | 0 -100.00% | 1.45M -99.31% | 0 -- | 11.10K -- | 46.28K -- | 66.00K -95.43% | 75.00K -- | 109.00K +881.81% | 142.00K +206.83% | 148.00K +124.24% | 169.00K +125.33% | 173.00K +58.72% | 76.00K -46.48% | 130.00K -12.16% | 6.27M +3611.24% | 132.00K -23.70% | 718.00K +844.74% | 7.25M -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.91M -- | -6.91M -- | 208.38M -- | 0 -- | 0 -100.00% | -208.38M -2913.91% | 1.45M -99.31% | 0 -- | 11.10K -- | -1.46M +99.30% | 66.00K -95.43% | 75.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 3.32M -- | 3.71M -- | 5.42M -- | 5.81M -- | 7.59M +128.38% | 34.26M +822.39% | 10.29M +89.92% | 9.41M +61.81% | 11.05M +45.58% | 13.43M -60.80% | 13.21M +28.40% | 13.18M +40.03% | 13.13M +18.81% | 14.05M +4.64% | 13.32M +0.85% | 16.77M +27.25% | 17.27M +31.55% | 20.29M +44.41% | 23.14M +73.71% | 23.32M +39.08% | 27.29M +58.06% | 31.83M +56.82% | 14.31M -38.15% | 11.68M -49.90% | 26.35M -3.45% | 17.71M -44.34% | 14.30M -0.06% | 12.81M +9.70% | 12.22M -53.63% | 14.96M -15.55% | 14.25M -0.40% | 12.14M -5.28% | 18.33M +50.01% | 17.57M +17.42% | 20.69M +45.20% | 13.40M +10.39% | 10.80M -41.09% | 12.68M -27.81% | 11.35M -45.16% | 12.65M -5.55% | 13.01M +20.49% | 49.69M -- |
Selling, General and Administrative Expenses | 2.18M -- | 2.59M -- | 3.65M -- | 3.12M -- | 3.60M +64.78% | 2.98M +15.07% | 4.21M +15.53% | 3.51M +12.63% | 4.33M +20.48% | 4.96M +66.40% | 5.09M +20.89% | 4.63M +31.96% | 4.50M +3.92% | 4.72M -4.82% | 4.20M -17.45% | 5.17M +11.59% | 5.16M +14.61% | 5.67M +20.20% | 7.11M +69.06% | 7.44M +44.01% | 10.41M +101.65% | 15.58M +174.77% | 6.63M -6.75% | 6.76M -9.11% | 8.26M -20.62% | 9.88M -36.57% | 8.26M +24.57% | 7.63M +12.82% | 6.66M -19.37% | 8.34M -15.55% | 8.25M -0.12% | 6.80M -10.83% | 7.69M +15.38% | 7.17M -14.09% | 8.10M -1.75% | 5.54M -18.53% | 4.88M -36.59% | 6.02M -16.00% | 4.88M -39.78% | 6.79M +22.38% | 6.42M +31.73% | 24.11M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 19.25M -- | -- -- | -- -- | -- -- | 30.63M +59.11% | -- -- | -- -- | -- -- | 37.23M +21.56% | -- -- | -- -- | -- -- | 32.43M -12.90% | -- -- | -- -- | 6.80M -- | 7.69M -76.30% | 7.17M -- | 8.10M -- | 5.54M -18.53% | 4.88M -36.59% | 6.02M -16.00% | 4.88M -39.78% | 6.79M +22.38% | 6.42M +31.73% | 24.11M -- |
Research and Development Expenses | 1.14M -- | 1.13M -- | 1.77M -- | 2.70M -- | 3.99M +250.25% | 31.28M +2676.88% | 6.07M +243.18% | 5.90M +118.59% | 6.71M +68.22% | 8.47M -72.91% | 8.12M +33.60% | 8.54M +44.84% | 8.62M +28.43% | 9.34M +10.18% | 9.12M +12.33% | 11.60M +35.73% | 12.11M +40.41% | 14.63M +56.63% | 16.03M +75.85% | 15.88M +36.88% | 16.88M +39.48% | 16.25M +11.10% | 7.68M -52.08% | 4.92M -69.02% | 18.09M +7.14% | 7.83M -51.80% | 6.05M -21.30% | 5.18M +5.41% | 5.56M -69.29% | 6.62M -15.54% | 6.00M -0.79% | 5.33M +2.89% | 10.64M +91.53% | 10.40M +57.17% | 12.58M +109.73% | 7.86M +47.29% | 5.92M -44.34% | 6.66M -35.95% | 6.46M -48.62% | 5.87M -25.27% | 6.59M +11.24% | 25.58M -- |
Operating Income | -3.32M -- | -3.71M -- | -5.42M -- | -5.81M -- | -7.59M -128.38% | -34.26M -822.39% | -10.29M -89.92% | -9.41M -61.81% | -11.05M -45.58% | -13.43M +60.80% | -13.21M -28.40% | -13.18M -40.03% | -13.13M -18.81% | -14.05M -4.64% | -13.32M -0.85% | -16.77M -27.25% | -17.27M -31.55% | -20.29M -44.41% | -23.14M -73.71% | -16.40M +2.16% | -21.59M -25.04% | 176.56M +969.98% | -14.31M +38.15% | -11.68M +28.79% | -26.35M -22.06% | -16.27M -109.21% | -14.30M +0.06% | -12.80M -9.61% | -12.17M +53.81% | -14.89M +8.45% | -14.17M +0.92% | -12.03M +6.05% | -18.19M -49.41% | -17.42M -16.95% | -20.52M -44.77% | -13.23M -9.95% | -10.72M +41.05% | -12.55M +27.94% | -5.07M +75.27% | -12.52M +5.32% | -12.29M -14.65% | -42.44M -- |
Non-Operating Income (Loss) | 30.28K -- | 32.33K -- | 31.31K -- | 29.69K -- | 27.50K -9.18% | 23.48K -27.36% | 39.72K +26.88% | 50.51K +70.13% | 87.80K +219.27% | 247.11K +952.28% | 274.56K +591.21% | 213.99K +323.70% | 226.36K +157.82% | 253.34K +2.52% | 265.00K -3.48% | 131.16K -38.71% | 298.72K +31.96% | 264.30K +4.32% | 590.49K +122.83% | -21.13K -116.11% | -438.26K -246.71% | -49.73K -118.82% | -2.52K -100.43% | 2.66K +112.58% | 3.90K +100.89% | 209.05K +520.35% | -284.13K -11188.32% | 836.09K +31367.26% | 668.12K +17018.19% | 1.54M +635.23% | 1.76M +720.85% | 776.00K -7.19% | 2.87M +329.11% | 5.72M +272.35% | 29.04M +1546.15% | -780.00K -200.52% | 1.47M -48.76% | 2.31M -59.55% | 389.00K -98.66% | 365.00K +146.79% | 21.96M +1394.69% | 25.03M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 131.16K -- | 298.72K -- | 264.30K -- | 590.49K -- | -21.13K -116.11% | -438.26K -246.71% | -49.73K -118.82% | -2.52K -100.43% | 2.66K +112.58% | 3.90K +100.89% | 209.05K +520.35% | -284.13K -11188.32% | 836.09K +31367.26% | 668.12K +17018.19% | 1.54M +635.23% | 1.76M +720.85% | 776.00K -7.19% | 2.87M +329.11% | 5.72M +272.35% | 29.04M +1546.15% | -780.00K -200.52% | 1.47M -48.76% | 2.31M -59.55% | 389.00K -98.66% | 365.00K +146.79% | 21.96M +1394.69% | 25.03M -- |
Net Interest Expense | -30.28K -- | -32.33K -- | -31.31K -- | -29.69K -- | -27.50K +9.18% | -23.48K +27.36% | -39.72K -26.88% | -50.51K -70.13% | -87.80K -219.27% | -247.11K -952.28% | -274.56K -591.21% | -213.99K -323.70% | -226.36K -157.82% | -253.34K -2.52% | -265.00K +3.48% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 30.28K -- | 32.33K -- | 31.31K -- | 29.69K -- | 27.50K -9.18% | 23.48K -27.36% | 39.72K +26.88% | 50.51K +70.13% | 87.80K +219.27% | 247.11K +952.28% | 274.56K +591.21% | 213.99K +323.70% | 226.36K +157.82% | 253.34K +2.52% | 265.00K -3.48% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.18M +61.50% | -12.94M -26.22% | -12.96M -38.50% | -12.90M -17.70% | -13.80M -4.68% | -13.06M -0.94% | -16.63M -28.34% | -16.97M -31.54% | -20.03M -45.14% | -22.55M -72.71% | -16.42M +1.26% | -22.03M -29.82% | 176.51M +981.21% | -14.32M +36.52% | -11.68M +28.89% | -26.35M -19.61% | -16.06M -109.10% | -14.59M -1.91% | -11.97M -2.47% | -11.50M +56.34% | -13.36M +16.83% | -12.41M +14.95% | -11.25M +5.97% | -15.32M -33.18% | -11.69M +12.44% | 8.52M +168.67% | -14.01M -24.46% | -9.25M +39.61% | -10.23M +12.48% | -4.68M -154.97% | -12.16M +13.19% | 9.66M +204.43% | -17.41M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 500.28K -- | 1.47M -- | -294.83K -- | -349.71K -- | 50.00K -90.01% | 0 -100.00% | 0 +100.00% | 0 +100.00% | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.18M +61.50% | -12.94M -26.22% | -12.96M -38.50% | -12.90M -17.70% | -13.80M -4.68% | -13.06M -0.94% | -16.63M -28.34% | -16.97M -31.54% | -20.03M -45.14% | -22.55M -72.71% | -16.42M +1.26% | -22.03M -29.82% | 176.01M +978.71% | -15.79M +29.99% | -11.38M +30.69% | -26.00M -18.02% | -16.11M -109.15% | -14.59M +7.60% | -11.97M -5.13% | -11.50M +55.75% | -13.36M +17.08% | -12.41M +14.95% | -11.25M +5.97% | -15.32M -33.18% | -11.69M +12.44% | 8.52M +168.67% | -14.01M -24.46% | -9.25M +39.61% | -10.23M +12.48% | -4.68M -154.97% | -12.16M +13.19% | 9.66M +204.43% | -17.41M -- |
Net Income Attributable to Owners of the Company | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.18M +61.50% | -12.94M -26.22% | -12.96M -38.50% | -12.90M -17.70% | -13.80M -4.68% | -13.06M -0.94% | -16.63M -28.34% | -16.97M -31.54% | -20.03M -45.14% | -22.55M -72.71% | -16.42M +1.26% | -22.03M -29.82% | 176.01M +978.71% | -15.79M +29.99% | -11.38M +30.69% | -26.00M -18.02% | -16.11M -109.15% | -14.59M +7.60% | -11.97M -5.13% | -11.50M +55.75% | -13.36M +17.08% | -12.41M +14.95% | -11.25M +5.97% | -15.32M -33.18% | -11.69M +12.44% | 8.52M +168.67% | -14.01M -24.46% | -9.25M +39.61% | -10.23M +12.48% | -4.68M -154.97% | -12.16M +13.19% | 9.66M +204.43% | -17.41M -- |
Net Income Attributable to Common Stockholders | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.18M +61.50% | -12.94M -26.22% | -12.96M -38.50% | -12.90M -17.70% | -13.80M -4.68% | -13.06M -0.94% | -16.63M -28.34% | -16.97M -31.54% | -20.03M -45.14% | -22.55M -72.71% | -16.42M +1.26% | -22.03M -29.82% | 176.01M +978.71% | -15.79M +29.99% | -11.38M +30.69% | -26.00M -18.02% | -16.11M -109.15% | -14.59M +7.60% | -11.97M -5.13% | -11.50M +55.75% | -13.36M +17.08% | -12.41M +14.95% | -11.25M +5.97% | -15.32M -33.18% | -11.69M +12.44% | 8.52M +168.67% | -14.01M -24.46% | -9.25M +39.61% | -10.23M +12.48% | -4.68M -154.97% | -12.16M +13.19% | 9.66M +204.43% | -17.41M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -35.91K -- | 19.89K -- | 11.35K -- | 2.85K -- | 3.18K +108.85% | -1.35K -106.79% | -- -- | 2.47K -13.25% | 63.23K +1889.15% | -65.70K -4766.96% | -- -- | 0 -100.00% | -- -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | -90.13K -- | 7.33K -- | 40.60K -- | 48.00K -- | -- -- | -9.00K -222.70% | -37.00K -191.12% | -20.00K -141.67% | 7.00K -- | 48.00K +633.33% | -70.00K -89.19% | -13.00K +35.00% | -12.00K -271.43% | -57.00K -218.75% | -76.00K -8.57% | -158.00K -- |
Total Comprehensive Income | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.22M +61.39% | -12.92M -26.02% | -12.95M -38.38% | -12.90M -17.67% | -13.80M -4.38% | -13.06M -1.11% | -16.63M -28.45% | -16.97M -31.55% | -19.97M -44.72% | -22.62M -73.20% | -16.42M +1.26% | -22.03M -29.84% | 176.01M +981.50% | -15.79M +30.19% | -11.38M +30.69% | -26.00M -18.02% | -16.11M -109.15% | -14.68M +7.03% | -11.96M -5.06% | -11.46M +55.91% | -13.31M +17.38% | -12.41M +15.47% | -11.26M +5.84% | -15.36M -33.97% | -11.71M +11.98% | 8.53M +168.73% | -13.96M -23.94% | -9.32M +39.30% | -10.25M +12.51% | -4.70M -155.07% | -12.21M +12.49% | 9.59M +202.83% | -17.57M -- |
Total Comprehensive Income Attributable to Owners of the Company | -3.29M -- | -3.68M -- | -5.39M -- | -5.79M -- | -7.56M -129.64% | -34.24M -829.86% | -10.25M -90.29% | -9.36M -61.77% | -10.96M -44.95% | -13.22M +61.39% | -12.92M -26.02% | -12.95M -38.38% | -12.90M -17.67% | -13.80M -4.38% | -13.06M -1.11% | -16.63M -28.45% | -16.97M -31.55% | -19.97M -44.72% | -22.62M -73.20% | -16.42M +1.26% | -22.03M -29.84% | 176.01M +981.50% | -15.79M +30.19% | -11.38M +30.69% | -26.00M -18.02% | -16.11M -109.15% | -14.68M +7.03% | -11.96M -5.06% | -11.46M +55.91% | -13.31M +17.38% | -12.41M +15.47% | -11.26M +5.84% | -15.36M -33.97% | -11.71M +11.98% | 8.53M +168.73% | -13.96M -23.94% | -9.32M +39.30% | -10.25M +12.52% | -4.70M -155.07% | -12.21M +12.49% | 9.59M +202.83% | -17.57M -- |
Basic EPS | -- -- | -0.37 -- | -0.55 -- | -0.59 -- | -0.36 -- | -3.48 -840.54% | -0.57 -3.64% | -0.38 +35.59% | -0.45 -25.00% | -0.54 +84.48% | -0.53 +7.02% | -0.53 -39.47% | -0.52 -15.56% | -0.46 +14.81% | -0.34 +35.85% | -0.43 +18.87% | -0.31 +40.38% | -0.37 +19.57% | -0.41 -20.59% | -0.28 +34.88% | -0.34 -9.68% | 2.55 +789.19% | -0.23 +43.90% | -0.17 +39.29% | -0.37 -8.82% | -0.23 -109.02% | -0.21 +8.70% | -0.17 -- | -0.16 +56.76% | -0.19 +17.39% | -0.18 +14.29% | -0.16 +5.88% | -0.22 -37.50% | -0.17 +10.53% | 0.12 +166.67% | -0.2 -25.00% | -0.13 +40.91% | -0.14 +17.65% | -0.06 -150.00% | -0.17 +15.00% | 0.07 +153.85% | -0.3 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.16 -- | -- -- | -0.17 -- | 0.12 -- | -0.2 -25.00% | -- -- | -0.14 +17.65% | -0.06 -150.00% | -0.17 +15.00% | -- -- | -- -- |
Diluted EPS | -- -- | -0.37 -- | -0.55 -- | -0.59 -- | -- -- | -3.48 -840.54% | -0.57 -3.64% | -0.38 +35.59% | -- -- | -0.54 +84.48% | -0.53 +7.02% | -0.53 -39.47% | -- -- | -0.46 +14.81% | -0.34 +35.85% | -0.43 +18.87% | -- -- | -0.37 +19.57% | -0.41 -20.59% | -0.28 +34.88% | -- -- | 2.53 +783.78% | -0.23 +43.90% | -0.17 +39.29% | -- -- | -0.23 -109.09% | -0.21 +8.70% | -0.17 -- | -- -- | -0.19 +17.39% | -0.18 +14.29% | -0.16 +5.88% | -- -- | -0.17 +10.53% | 0.12 +166.67% | -0.2 -25.00% | -- -- | -0.14 +17.65% | -0.06 -150.00% | -0.17 +15.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.16 -- | -- -- | -0.17 -- | 0.12 -- | -0.2 -25.00% | -- -- | -0.14 +17.65% | -0.06 -150.00% | -0.17 +15.00% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Ovid Therapeutics’s earnings call?What were the key takeaways from Ovid Therapeutics's earnings call?What does Ovid Therapeutics do and what are its main business segments?What factors drove the changes in Ovid Therapeutics's revenue and profit?What guidance did Ovid Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Ovid Therapeutics year over year?Did Ovid Therapeutics beat or miss consensus estimates last quarter?What is Ovid Therapeutics's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
